<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36148819</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases.</ArticleTitle><Pagination><StartPage>47</StartPage><EndPage>56</EndPage><MedlinePgn>47-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.15570</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Mild behavioral impairment (MBI) has been increasingly regarded as the neurobehavioral axis of predementia risk states, but a specific investigation of its detection as a potential marker of prodromal dementia in motor neuron diseases (MNDs) is still lacking. The aims of our study were therefore to explore MBI in MNDs both at onset and over the disease course, and to evaluate its relationship with baseline and longitudinal cognitive features.</AbstractText><AbstractText Label="METHODS">Sixty MND patients with cognitive/behavioral, mood, and motor examinations were recruited and followed longitudinally for up to 15&#x2009;months. Associations between baseline MBI symptoms and clinical features were tested using the Spearman correlation coefficient. Based on longitudinal data, relative deltas of variation for each cognitive measure were generated, and linear regression models were then used to evaluate the role of baseline MBI symptoms in predicting longitudinal rates of cognitive decline.</AbstractText><AbstractText Label="RESULTS">At disease onset, the most impaired MBI domain was affective/emotional dysregulation, followed by impulse dyscontrol, apathy, and social inappropriateness. Greater MBI symptoms correlated with more severe baseline motor, cognitive/behavioral, and mood disturbances (p values from &lt;0.001 to 0.05). Longitudinally, the greatest decline was observed in the affective/emotional dysregulation domain, followed by impulse dyscontrol, apathy, and social inappropriateness. Greater MBI symptoms at onset were significant predictors of more severe longitudinal cognitive decline in both amyotrophic lateral sclerosis (ALS)-specific and ALS-nonspecific functions (p values from &lt;0.001 to 0.03).</AbstractText><AbstractText Label="CONCLUSIONS">MBI represents a valuable clinical marker of incident cognitive decline in MNDs, and its evaluation has good potential for detecting dementia in its preclinical/prodromal phase.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Pilar M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-5008-2791</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gervino</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Maria</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponzano</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4091-4686</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4740-1982</Identifier><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Signori</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6289-9144</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schenone</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roccatagliata</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8029-3947</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caponnetto</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5547-3900</Identifier><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">longitudinal cognitive decline</Keyword><Keyword MajorTopicYN="N">mild behavioral impairment</Keyword><Keyword MajorTopicYN="N">motor neuron diseases</Keyword><Keyword MajorTopicYN="N">prodromal dementia</Keyword></KeywordList><CoiStatement>All authors have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36148819</ArticleId><ArticleId IdType="pmc">PMC10091712</ArticleId><ArticleId IdType="doi">10.1111/ene.15570</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ismail Z, Smith EE, Geda Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12:195&#x2010;202. doi:10.1016/j.jalz.2015.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.017</ArticleId><ArticleId IdType="pmc">PMC4684483</ArticleId><ArticleId IdType="pubmed">26096665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, Ag&#xfc;era&#x2010;Ortiz L, Brodaty H, et al. The Mild Behavioral Impairment Checklist (MBI&#x2010;C): a rating scale for neuropsychiatric symptoms in pre&#x2010;dementia populations. J Alzheimers Dis. 2017;56:929&#x2010;938. doi:10.3233/JAD-160979</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160979</ArticleId><ArticleId IdType="pmc">PMC5652315</ArticleId><ArticleId IdType="pubmed">28059789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Shea YF, Li S, et al. Prevalence of mild behavioural impairment: a systematic review and meta&#x2010;analysis. Psychogeriatrics. 2021;21:100&#x2010;111. doi:10.1111/psyg.12636</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12636</ArticleId><ArticleId IdType="pubmed">33260271</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon EJ, Ismail Z, Hanganu A, et al. Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease. Neurology. 2019;93:e766&#x2010;e777. doi:10.1212/WNL.0000000000007968</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007968</ArticleId><ArticleId IdType="pmc">PMC6711660</ArticleId><ArticleId IdType="pubmed">31320470</ArticleId></ArticleIdList></Reference><Reference><Citation>Taragano FE, Allegri RF, Heisecke SL, et al. Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. J Alzheimers Dis. 2018;62:227&#x2010;238. doi:10.3233/JAD-170632</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170632</ArticleId><ArticleId IdType="pubmed">29439333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, McGirr A, Gill S, Hu S, Forkert ND, Smith EE. Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline. J Alzheimers Dis. 2021;80:459&#x2010;469. doi:10.3233/JAD-201184</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201184</ArticleId><ArticleId IdType="pmc">PMC8075401</ArticleId><ArticleId IdType="pubmed">33554909</ArticleId></ArticleIdList></Reference><Reference><Citation>Orso B, Mattei C, Arnaldi D, et al. Clinical and MRI predictors of conversion from mild behavioural impairment to dementia. Am J Geriatr Psychiatry. 2020;28:755&#x2010;763. doi:10.1016/j.jagp.2019.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2019.12.007</ArticleId><ArticleId IdType="pubmed">31928846</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population&#x2010;based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86:168&#x2010;173. doi:10.1136/jnnp-2013-307223</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:994&#x2010;1003. doi:10.1016/S1474-4422(07)70265-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70265-X</ArticleId><ArticleId IdType="pubmed">17945153</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxon JA, Thompson JC, Jones M, et al. Examining the language and behavioural profile in FTD and ALS&#x2010;FTD. J Neurol Neurosurg Psychiatry. 2017;88:675&#x2010;680. doi:10.1136/jnnp-2017-315667</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315667</ArticleId><ArticleId IdType="pmc">PMC5537548</ArticleId><ArticleId IdType="pubmed">28596248</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310&#x2010;323. doi:10.3109/17482960802566824</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263&#x2010;1269. doi:10.1212/WNL.0b013e318214359f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318214359f</ArticleId><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf J, Safer A, W&#xf6;hrle JC, et al. Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis &#x2013; Data from a population&#x2010;based registry. J Neurol Sci. 2014;345:164&#x2010;167. doi:10.1016/j.jns.2014.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.07.033</ArticleId><ArticleId IdType="pubmed">25086855</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Iannaccone S, Cerami C, et al. The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol. 2013;27:143&#x2010;153. doi:10.3233/BEN-2012-110202</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BEN-2012-110202</ArticleId><ArticleId IdType="pmc">PMC5215720</ArticleId><ArticleId IdType="pubmed">23001631</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis &#x2013; frontotemporal spectrum disorder (ALS&#x2010;FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153&#x2010;174. doi:10.1080/21678421.2016.1267768</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2010;2477. doi:10.1093/brain/awr179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson M, Chotai J, Nordst&#xf6;m A, Bodlund O. Comparison of two self&#x2010;rating scales to detect depression: HADS and PHQ&#x2010;9. Br J Gen Pract. 2009;59:e283&#x2010;e288. doi:10.3399/bjgp09X454070</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp09X454070</ArticleId><ArticleId IdType="pmc">PMC2734374</ArticleId><ArticleId IdType="pubmed">19761655</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1:293&#x2010;299. doi:10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740&#x2010;746. doi:10.1136/jnnp.2010.235952</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9&#x2010;14. doi:10.3109/21678421.2013.805784</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489&#x2010;498. doi:10.1080/21678421.2016.1183679</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1183679</ArticleId><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Elefante C, Lattanzi L, Ismail Z, et al. Mild behavioral impairment: presentation of the diagnostic criteria and the Italian version of the MBI&#x2010;Checklist. Riv Psichiatr. 2019;54:59&#x2010;66. doi:10.1708/3142.31246</Citation><ArticleIdList><ArticleId IdType="doi">10.1708/3142.31246</ArticleId><ArticleId IdType="pubmed">30985830</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361&#x2010;370. doi:10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, Trojsi F, et al. Edinburgh Cognitive and Behavioural ALS Screen (ECAS)&#x2010;Italian version: regression based norms and equivalent scores. Neurol Sci. 2017;38:1059&#x2010;1068. doi:10.1007/s10072-017-2919-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-017-2919-4</ArticleId><ArticleId IdType="pubmed">28332040</ArticleId></ArticleIdList></Reference><Reference><Citation>Creese B, Griffiths A, Brooker H, et al. Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults. Int Psychogeriatr. 2020;32:705&#x2010;717. doi:10.1017/S1041610219001200</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610219001200</ArticleId><ArticleId IdType="pubmed">31526407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2011;12:45&#x2010;51. doi:10.3109/17482968.2010.520718</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.520718</ArticleId><ArticleId IdType="pubmed">20849323</ArticleId></ArticleIdList></Reference><Reference><Citation>Witgert M, Salamone AR, Strutt AM, et al. Frontal&#x2010;lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:103&#x2010;110. doi:10.1111/j.1468-1331.2009.02801.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02801.x</ArticleId><ArticleId IdType="pubmed">19874396</ArticleId></ArticleIdList></Reference><Reference><Citation>Passamonti L, Fera F, Tessitore A, et al. Dysfunctions within limbic&#x2010;motor networks in amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34:2499&#x2010;2509. doi:10.1016/j.neurobiolaging.2013.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.05.016</ArticleId><ArticleId IdType="pubmed">23806980</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Diekmann V, Anders S, et al. Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). J Neurol. 2007;254:519&#x2010;527. doi:10.1007/s00415-006-0409-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0409-3</ArticleId><ArticleId IdType="pubmed">17401515</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney NT, Goodkind MS, Lomen&#x2010;Hoerth C, et al. Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis. Brain. 2011;134:3458&#x2010;3469. doi:10.1093/brain/awr297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr297</ArticleId><ArticleId IdType="pmc">PMC3235565</ArticleId><ArticleId IdType="pubmed">22155983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons ZC, Richardson A, Neary D, Snowden JS. Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:67&#x2010;74. doi:10.1080/17482960701642437</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701642437</ArticleId><ArticleId IdType="pubmed">18427998</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordana MT, Ferrero P, Grifoni S, Pellerino A, Naldi A, Montuschi A. Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci. 2011;32:9&#x2010;16. doi:10.1007/s10072-010-0439-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-010-0439-6</ArticleId><ArticleId IdType="pubmed">20953810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Hodges JR. Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients' behavioral changes than physical disability: a comparative study. BMC Neurol. 2012;12:156. doi:10.1186/1471-2377-12-156</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-12-156</ArticleId><ArticleId IdType="pmc">PMC3541170</ArticleId><ArticleId IdType="pubmed">23216745</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, et al. ALS&#x2010;specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370&#x2010;e1380. doi:10.1212/WNL.0000000000006317</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006317</ArticleId><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Harris J, Richardson A, et al. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:172&#x2010;176. doi:10.3109/21678421.2013.765485</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.765485</ArticleId><ArticleId IdType="pubmed">23421625</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Alruwaili ARS, Henderson RD, McCombe PA. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival. J Neurol Sci. 2017;376:16&#x2010;23. doi:10.1016/j.jns.2017.02.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.02.061</ArticleId><ArticleId IdType="pubmed">28431606</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Turner MR, Hsieh S, et al. Apathy is associated with poor prognosis in amyotrophic lateral sclerosis. Eur J Neurol. 2016;23:891&#x2010;897. doi:10.1111/ene.12959</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12959</ArticleId><ArticleId IdType="pubmed">26822417</ArticleId></ArticleIdList></Reference><Reference><Citation>Bersano E, Sarnelli MF, Solara V, et al. Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:373&#x2010;379. doi:10.1080/21678421.2020.1771732</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1771732</ArticleId><ArticleId IdType="pubmed">32484726</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin JG, Albert SM, Del Bene ML, et al. Prevalence of depressive disorders and change over time in late&#x2010;stage ALS. Neurology. 2005;65:62&#x2010;67. doi:10.1212/01.wnl.0000167187.14501.0c</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000167187.14501.0c</ArticleId><ArticleId IdType="pmc">PMC1201558</ArticleId><ArticleId IdType="pubmed">16009886</ArticleId></ArticleIdList></Reference><Reference><Citation>Benbrika S, Desgranges B, Eustache F, Viader F. Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review. Front Neurosci. 2019;13:951. doi:10.3389/fnins.2019.00951</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00951</ArticleId><ArticleId IdType="pmc">PMC6746914</ArticleId><ArticleId IdType="pubmed">31551700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen&#x2010;Hoerth C. Progression and effect of cognitive&#x2010;behavioral changes in patients with amyotrophic lateral sclerosis. Neurol Clin Pract. 2017;7:488&#x2010;498. doi:10.1212/CPJ.0000000000000397</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000397</ArticleId><ArticleId IdType="pmc">PMC5800712</ArticleId><ArticleId IdType="pubmed">29431172</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley S, Goetz R, Factor&#x2010;Litvak P, et al. Longitudinal screening&#xa0;detects cognitive stability and behavioral deterioration in ALS&#xa0;patients. Behav Neurol. 2018;2018:1&#x2010;7. doi:10.1155/2018/5969137</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5969137</ArticleId><ArticleId IdType="pmc">PMC6234441</ArticleId><ArticleId IdType="pubmed">30515252</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt C, Neuwirth C, Weber M. Longitudinal assessment of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): lack of practice effect in ALS patients? Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:202&#x2010;209. doi:10.1080/21678421.2017.1283418</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1283418</ArticleId><ArticleId IdType="pubmed">28165766</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, et al. Cognitive&#x2010;behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:387&#x2010;395. doi:10.1080/21678421.2018.1473443</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1473443</ArticleId><ArticleId IdType="pubmed">29804470</ArticleId></ArticleIdList></Reference><Reference><Citation>Creese B, Brooker H, Ismail Z, et al. Mild Behavioral Impairment as a marker of cognitive decline in cognitively normal older adults. Am J Geriatr Psychiatry. 2019;27:823&#x2010;834. doi:10.1016/j.jagp.2019.01.215</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2019.01.215</ArticleId><ArticleId IdType="pubmed">30902566</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman A, Woolley&#x2010;Levine S, Bradley W, Miller R. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:56&#x2010;61. doi:10.1080/17482960601044106</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960601044106</ArticleId><ArticleId IdType="pubmed">17364437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa K, Yasuda N, Fukuda M, et al. Syntactic comprehension in patients with amyotrophic lateral sclerosis. Behav Neurol. 2014;2014:1&#x2010;8. doi:10.1155/2014/230578</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/230578</ArticleId><ArticleId IdType="pmc">PMC4006623</ArticleId><ArticleId IdType="pubmed">25161339</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology. 1999;53:1665. doi:10.1212/wnl.53.8.1665</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.53.8.1665</ArticleId><ArticleId IdType="pubmed">10563610</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Ogino M, Ichikawa H, Hanajima R, Nakashima K. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:66&#x2010;72. doi:10.1080/21678421.2020.1801751</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1801751</ArticleId><ArticleId IdType="pubmed">32757854</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>